Sabra Health Care Reit Inc. logo

Sabra Health Care Reit Inc. (SOB)

Market Closed
12 Dec, 20:00
XSTU XSTU
15. 89
-0.12
-0.78%
- Market Cap
227.67 P/E Ratio
1.2% Div Yield
0 Volume
0.58 Eps
16.01
Previous Close
Day Range
15.89 15.89
Year Range
14.24 16.83
Want to track SOB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 67 days

Summary

SOB closed today lower at €15.89, a decrease of 0.78% from yesterday's close, completing a monthly increase of 3.92% or €0.6. Over the past 12 months, SOB stock lost -3.99%.
SOB pays dividends to its shareholders, with the most recent payment made on Nov 28, 2025. The next estimated payment will be in In 2 months on Feb 28, 2026 for a total of €0.3.
The last earnings report, released on Nov 05, 2025, missed the consensus estimates by -0.38%. On average, the company has fell short of earnings expectations by -0.19%, based on the last three reports. The next scheduled earnings report is due on Feb 18, 2026.
Sabra Health Care Reit Inc. has completed 1 stock splits, with the recent split occurring on Nov 16, 2010.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

SOB Chart

Sabra Health Care REIT, Inc. (SBRA) Q3 2025 Earnings Call Transcript

Sabra Health Care REIT, Inc. (SBRA) Q3 2025 Earnings Call Transcript

Sabra Health Care REIT, Inc. ( SBRA ) Q3 2025 Earnings Call November 6, 2025 1:00 PM EST Company Participants Lukas Hartwich - Executive Vice President of Finance Rick Matros - Chairman, President & CEO Talya Nevo-Hacohen - Executive VP, Chief Investment Officer & Treasurer Darrin Smith - Executive Vice President of Investments Michael Costa - Executive VP, CFO & Secretary Conference Call Participants Farrell Granath - BofA Securities, Research Division Austin Wurschmidt - KeyBanc Capital Markets Inc., Research Division William John Kilichowski - Wells Fargo Securities, LLC, Research Division Seth Bergey - Citigroup Inc., Research Division Juan Sanabria - BMO Capital Markets Equity Research Richard Anderson - Cantor Fitzgerald & Co., Research Division Alec Feygin - Robert W. Baird & Co. Incorporated, Research Division Michael Stroyeck - Green Street Advisors, LLC, Research Division Omotayo Okusanya - Deutsche Bank AG, Research Division Presentation Operator Good day, everyone.

Seekingalpha | 1 month ago
Sabra (SBRA) Reports Q3 Earnings: What Key Metrics Have to Say

Sabra (SBRA) Reports Q3 Earnings: What Key Metrics Have to Say

The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 1 month ago
Sabra Healthcare (SBRA) Meets Q3 FFO Estimates

Sabra Healthcare (SBRA) Meets Q3 FFO Estimates

Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.38 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.37 per share a year ago.

Zacks | 1 month ago

Sabra Health Care Reit Inc. (SOB) FAQ

What is the stock price today?

The current price is €15.89.

On which exchange is it traded?

Sabra Health Care Reit Inc. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is SOB.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.2%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.38.

When is the next earnings date?

The next earnings report will release on Feb 18, 2026.

Has Sabra Health Care Reit Inc. ever had a stock split?

Sabra Health Care Reit Inc. had 1 splits and the recent split was on Nov 16, 2010.

Sabra Health Care Reit Inc. Profile

Health Care REITs Industry
Real Estate Sector
Richard K. Matros CEO
XSTU Exchange
US78573L1061 ISIN
US Country
50 Employees
17 Nov 2025 Last Dividend
16 Nov 2010 Last Split
2 Apr 2002 IPO Date

Overview

Sabra is a company that has established a significant presence in the real estate industry by focusing on healthcare-related properties. As of September 30, 2023, Sabra’s comprehensive investment portfolio encompasses a wide variety of facilities and investments designed to cater to the healthcare sector, primarily in the United States and Canada. Their portfolio diversification extends across skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, specialty hospitals, and other related investments, including loans receivable, preferred equity investments, and investments in unconsolidated joint ventures. With a focus on the growing demand for healthcare services, especially among the aging population, Sabra has positioned itself as a key player in the healthcare real estate investment market.

Products and Services

  • Skilled Nursing/Transitional Care facilities
  • These facilities are designed to provide specialized nursing care and rehabilitation services for patients transitioning from hospital to home. Sabra’s portfolio includes 240 of these facilities, reflecting a significant focus on supporting recovery and rehabilitation.

  • Senior Housing - Leased
  • Sabra owns 43 senior housing communities that are leased to operators. These communities offer residential care and services for seniors, ensuring they have access to comfortable living arrangements alongside necessary support services.

  • Senior Housing - Managed
  • With 61 communities, these senior housing properties are operated by third-party managers under property management agreements. This arrangement allows Sabra to benefit from specialized operational expertise while maintaining ownership.

  • Behavioral Health facilities
  • These 18 facilities focus on providing care and support for individuals with behavioral health issues, including mental health and substance abuse disorders, thereby addressing a critical need within the healthcare spectrum.

  • Specialty Hospitals and Other facilities
  • This diverse category includes 15 facilities ranging from specialty hospitals that provide targeted medical services to various other healthcare-related properties, showing Sabra’s investment in broad healthcare needs.

  • Loans Receivable
  • Comprising two mortgage loans and 10 other loans, these financial products represent Sabra’s involvement in financing real estate transactions in the healthcare sector, providing capital for growth and operations.

  • Preferred Equity Investments
  • With five preferred equity investments, Sabra engages in strategic financial placements in companies or projects within its domain, offering a blend of equity and debt benefits.

  • Investments in Unconsolidated Joint Ventures
  • These two investments showcase Sabra’s collaborative approach to investment, working alongside partners to leverage opportunities within the healthcare real estate market more effectively.

Contact Information

Address: 18500 Von Karman Avenue
Phone: 888-393-8248